Investigation of potential biomarkers of biochemically recurrent prostate cancer

被引：0
|
作者：
Demidenko, R. [1 ]
Daniunaite, K. [1 ]
Laurinavicius, A. [2 ]
Jankevicius, F. [3 ]
Jarmalaite, S. [1 ]
Lazutka, J. R. [1 ]
机构：
[1] Vilnius State Univ, Div Human Genome Res Ctr, Vilnius, Lithuania
[2] Vilnius State Univ, Dept Pathol Forens Med & Pharmacol, Vilnius, Lithuania
[3] Vilnius State Univ, Dept Urol, Vilnius, Lithuania
来源：
FEBS JOURNAL | 2014年 / 281卷
关键词：
Biomarker; gene expression; prostate cancer;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TUE-146
引用
收藏
页码：481 / 481
页数：1
相关论文
共 50 条
  • [41] The EMBARK trial: The use of enzalutamide in biochemically recurrent prostate cancer after primary therapy
    Shelan, Mohamed
    Mathier, Etienne
    Aebersold, Daniel M.
    Wiegel, Thomas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2025,
  • [42] High-Dose Itraconazole As a Noncastrating Therapy for a Patient With Biochemically Recurrent Prostate Cancer
    Suzman, Daniel L.
    Antonarakis, Emmanuel S.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (02) : E51 - E53
  • [43] Salvage hypofractionated radiation therapy for biochemically recurrent prostate cancer following radical prostatectomy
    Churas, K. L. P.
    Wong, G.
    Jarrard, D. F.
    Paolone, D. R.
    Graf, A. K.
    Hedican, S. P.
    Wegenke, J. D.
    Ritter, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S352 - S352
  • [44] Erratum to: ‘Clinical impact of PSMA PET in biochemically recurrent prostate cancer; a review of the literature’
    Maurits Wondergem
    Friso M. van der Zant
    Wouter A. M. Broos
    Remco J. J. Knol
    Tijdschrift voor Urologie, 2020, 10 (6-7) : 122 - 123
  • [45] The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer
    Crook, Juanita
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) : 258 - 264
  • [46] Impact of radiation doses on clinical relapse of biochemically recurrent prostate cancer after prostatectomy
    Seiya Takano
    Natsuo Tomita
    Masanari Niwa
    Akira Torii
    Taiki Takaoka
    Nozomi Kita
    Kaoru Uchiyama
    Mikiko Nakanishi-Imai
    Shiho Ayakawa
    Masato Iida
    Yusuke Tsuzuki
    Shinya Otsuka
    Yoshihiko Manabe
    Kento Nomura
    Yasutaka Ogawa
    Akifumi Miyakawa
    Akihiko Miyamoto
    Shinya Takemoto
    Takahiro Yasui
    Akio Hiwatashi
    Scientific Reports, 14
  • [47] The Role of Intermittent Androgen Deprivation Therapy in the Management of Biochemically Recurrent or Metastatic Prostate Cancer
    Jaswal, Jasbir
    Crook, Juanita
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [48] Kallikrein gene family as biomarkers for recurrent prostate cancer
    Boyukozer, Fatma Busra
    Tanoglu, Esra Guzel
    Ozen, Mustafa
    Ittmann, Michael
    Asian, Elif Sibel
    CROATIAN MEDICAL JOURNAL, 2020, 61 (05) : 450 - 456
  • [49] PSMA PET vs. pelvic MRI in biochemically recurrent prostate cancer.
    Sonni, Ida
    Murthy, Vishnu
    Mehta, Raj
    Chung, Alex
    Unterrainer, Lena
    Hotta, Masatoshi
    Farolfi, Andrea
    Benitez, Cecil
    Armstrong, Wesley Robert
    Doddipalli, Sahith
    Bandara, Anishka
    Valle, Luca
    Kishan, Amar Upadhyaya
    Benz, Matthias R.
    Raman, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [50] A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer
    T B Dorff
    S Groshen
    D D Tsao-Wei
    S Xiong
    M E Gross
    N Vogelzang
    D I Quinn
    J K Pinski
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 359 - 365
12345